NDAINTRAVENOUSINJECTABLE
Approved
Aug 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
AMMONIA N 13 (nh3n13) by Medica Corp is radiopharmaceutical activity [moa]. First approved in 2007.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMMONIA N 13 (NH3N13) is a radioactive diagnostic agent administered intravenously for nuclear medicine imaging. It functions as a radiopharmaceutical that leverages N-13 radionuclide activity to visualize metabolic and perfusion abnormalities. The drug enables clinicians to detect tissue viability and regional blood flow in cardiac and neurological imaging.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting consolidation of team resources and focus on operational efficiency rather than expansion.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMMONIA N 13 positions professionals in the specialized radiopharmaceutical sector with deep expertise in nuclear medicine and diagnostic imaging. Career growth depends on lateral movement into broader oncology or cardiology diagnostics portfolios rather than vertical advancement on this mature asset.
Diagnostic Imaging Specialist
Worked on AMMONIA N 13 at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.